NCT03801551View on ClinicalTrials.gov

Validation of a Tool for the Dimensional Assessment of Apathy in a Population Suffering From Schizophrenia.

NACompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

July 3, 2018

Primary Completion Date

October 22, 2020

Study Completion Date

October 22, 2020

Conditions
Schizophrenia
Interventions
DIAGNOSTIC_TEST

Validate according to psychometric criteria, a dimensional measure of apathy in a population suffering from schizophrenia spectrum disorder and other psychotic disorders (according to DSM-5 criteria).

Validate according to psychometric criteria, a dimensional measure of apathy in a population suffering from schizophrenia spectrum disorder and other psychotic disorders (according to DSM-5 criteria).

Trial Locations (2)

79021

Centre Hospitalier de Niort, Niort

87025

Centre Hospitalier Esquirol, Limoges

All Listed Sponsors
lead

Centre Hospitalier de Niort

OTHER

NCT03801551 - Validation of a Tool for the Dimensional Assessment of Apathy in a Population Suffering From Schizophrenia. | Biotech Hunter | Biotech Hunter